Greenwich Lifesciences Inc (GLSI)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 161.52M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 16.50
52W Low
$ 8.06
Dividend Yield
0.00%
Beta
3.16
Technicals
50-Day MA
10.7402
200-Day MA
11.3878
52 Week High
16.5
52 Week Low
8.06
About GLSI
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in United States and Romania.
Employees
4
Headquarters
Stafford, TX
CEO
Mr. Snehal S. Patel